<p><b>Cumulative probability of event-free survival for (A) myocardial infarction, (B) cerebrovascular accident, (C) cardiovascular death, and (D) primary composite endpoint.</b> The primary outcome was a composite of myocardial infarction (MI), cerebrovascular accident (CVA), or cardiovascular death. A higher recurrent MI rate in the IABP group than the Nonuser group (7% versus 6.9%, p = 0.001). The rate of CVA was similar between the two groups (5% versus 6.3%, p = 0.654). A higher cardiovascular death rate in the IABP group than the Nonuser group (36.9% versus 24%, p<0.001). More composite primary outcome occurred in IABP group than Nonuser group (45.2% versus 34.1%, p<0.001).</p
Context Cardiogenic shock (CS) is the leading cause of death for patients hospitalized with acute my...
Context: Intra-aortic balloon counterpulsation (IABC) is an adjunct to revascularization in patients...
The Intra Aortic Balloon Pump (IABP) is an es-tablished support in addition to pharmacologic treat-m...
Prior studies have suggested intraaortic balloon pump (IABP) have a neutral effect on acute myocardi...
<div><p>Background</p><p>Prior studies have suggested intraaortic balloon pump (IABP) have a neutral...
Background: Intra-aortic balloon pump (IABP) has been widely used ever since it was first developed ...
Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated by cardiog...
BACKGROUND: The aim of this study was to investigate the clinical effects of intra-aortic balloon pu...
Despite recent advances in the treatment of acute myocardial infarction (AMI), the mortality of AMI ...
Background: In the current international guidelines, intra-aortic balloon pump (IABP) counterpulsati...
Background: Previous studies showed that patients with cardiogenic shock (CS) from ST-elevation acut...
Background\ud In the current international guidelines, intra-aortic balloon pump (IABP) counterpulsa...
Background Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated...
Background: Intra-aortic balloon pump (IABP) has been widely used ever since it was first developed ...
Background: Cardiogenic shock is a serious complication of a ST-segment elevation myocardial infarct...
Context Cardiogenic shock (CS) is the leading cause of death for patients hospitalized with acute my...
Context: Intra-aortic balloon counterpulsation (IABC) is an adjunct to revascularization in patients...
The Intra Aortic Balloon Pump (IABP) is an es-tablished support in addition to pharmacologic treat-m...
Prior studies have suggested intraaortic balloon pump (IABP) have a neutral effect on acute myocardi...
<div><p>Background</p><p>Prior studies have suggested intraaortic balloon pump (IABP) have a neutral...
Background: Intra-aortic balloon pump (IABP) has been widely used ever since it was first developed ...
Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated by cardiog...
BACKGROUND: The aim of this study was to investigate the clinical effects of intra-aortic balloon pu...
Despite recent advances in the treatment of acute myocardial infarction (AMI), the mortality of AMI ...
Background: In the current international guidelines, intra-aortic balloon pump (IABP) counterpulsati...
Background: Previous studies showed that patients with cardiogenic shock (CS) from ST-elevation acut...
Background\ud In the current international guidelines, intra-aortic balloon pump (IABP) counterpulsa...
Background Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated...
Background: Intra-aortic balloon pump (IABP) has been widely used ever since it was first developed ...
Background: Cardiogenic shock is a serious complication of a ST-segment elevation myocardial infarct...
Context Cardiogenic shock (CS) is the leading cause of death for patients hospitalized with acute my...
Context: Intra-aortic balloon counterpulsation (IABC) is an adjunct to revascularization in patients...
The Intra Aortic Balloon Pump (IABP) is an es-tablished support in addition to pharmacologic treat-m...